Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations

Peritoneal Dialysis International

Volumn 24, Issue 4, 2004, Pages 340-346

  McDonald, Stephen P ^a   Collins, John F ^c   Rumpsfeld, Markus ^b   Johnson, David W ^a,b  

^a ANZDATA Registry   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Body mass index; Kidney failure chronic therapy; Nutritional status; Peritonitis; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; AUSTRALIA; BODY MASS; CHRONIC LUNG DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEW ZEALAND; OBESITY; OUTCOMES RESEARCH; PATIENT CODING; PERITONEAL DIALYSIS; PERITONITIS; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNDERWEIGHT;

EID: 4444338036     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080402400408     Document Type: Review

References (23)

1. Craft PS, May J, Dorigo A, Hoy C, Plant A. Hickman catheters: left-sided insertion, male gender, and obesity are associated with an increased risk of complications. Aust N Z J Med 1996; 26:33-9.
2. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002; 17:1802-7.
3. Afthentopoulos IE, Oreopoulos DG. Is CAPD an effective treatment for ESRD patients with a weight over 80 kg? Clin Nephrol 1997; 47:389-93.
4. Piraino B, Bernardini J, Centa PK, Johnston JR, Sorkin MI. The effect of body weight on CAPD related infections and catheter loss. Perit Dial Int 1991; 11:64-8.
5. Russ GR. ANZDATA Registry Report 2002. Adelaide: Australia & New Zealand Dialysis and Transplant Registry; 2002.
6. Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, et al. Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 2000; 20:715-21.
7. Australia and New Zealand Dialysis and Transplant Registry. Data collection form. Accessed 29/7/03. Available from: http://www.anzdata.org.au/forms/ANZFORM2002.pdf
8. National Health and Medical Research Council of Australia: Report of the 100th Session. Canberra: Australian Government Publishing Service; 1985.
9. McDonald SP, Collins J, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australian and New Zealand patient populations. J Am Soc Nephrol 2003; 14:2894-901.
10. Lin D, Wei L. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84:1074-8.
11. Forbes A, Wolfe R. Analysis of studies with correlated data: a simple approach using robust standard errors. Australasian Epidemiologist 2001; 8:13-16.
12. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
13. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9:1285-92.
14. European Renal Association Registry. Annual Report 2000. Amsterdam: European Renal Association-European Dialysis and Transplant Association; 2000.
15. Strauss RJ, Wise L. Operative risks of obesity. Surg Gynecol Obstet 1978; 146:286-91.
16. Twardowski ZJ, Prowant BF. Exit-site healing post catheter implantation. Perit Dial Int 1996; 16(Suppl 3):S51-70.
17. Piraino B, Bender F, Bernardini J. A comparison of clearances on tidal peritoneal dialysis and intermittent peritoneal dialysis. Perit Dial Int 1994; 14:145-8.
18. Blake P, Burkart JM, Churchill DN, Daugirdas J, Depner T, Hamburger RJ, et al. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16:448-56.
19. Tzamaloukas AH, Dimitriadis A, Murata GH, Nicolopoulou N, Malhotra D, Balaskas EV, et al. Continuous peritoneal dialysis in heavyweight individuals: urea and creatinine clearances. Perit Dial Int 1996; 16:302-6.
20. Tzamaloukas AH, Murata GH. Peritoneal dialysis in patients with large body size: can it deliver adequate clearances? Perit Dial Int 1999; 19:409-14.
21. Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 2000; 20:429-38.
22. Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, et al. Predictors of residual renal function decline in new peritoneal dialysis patients. Perit Dial Int 2003; 23:276-83.
23. Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PMM, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003; 64:2222-8.